Medicare and Medicaid
Featured Topics
Lead story
Other featured articles
-
Comparative Effectiveness of Placental Allografts in the Treatment of Diabetic Lower Extremity Ulcers and Venous Leg Ulcers in U.S. Medicare Beneficiaries: A Retrospective Observational Cohort Study Using Real-World Evidence
DLEUs and VLUs treated with vCPM and vLPM allografts are associated with lowered 1-year mortality, wound recurrence, and AOs in DLEUs and VLUs compared with standard care. Decision makers weighing coverage of placental allografts should consider these added short- and long-term clinical benefits relative to costly management and high mortality of Medicare’s most frequent wounds.
Posted in -
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
The new weight loss drugs work, and represent huge value in treating obesity. Even though they are expensive, broader access to them via Medicare would end up saving the U.S. money.
Posted in -
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Posted in -
Medicare’s Mental Health Care Problem
Mental health care providers are subject to unique constraints and incentives, compared to other specialists.
Posted in
About this section
The nation’s growing debt threatens Medicare and Medicaid, which have helped countless Americans and reduced poverty. Schaeffer Center researchers work with legislators on a bipartisan basis to bolster these vital systems, making them more efficient and effective.
Our Work In Medicare and Medicaid
-
Seminar Series – Boris Vabson
Boris Vabson is a research faculty member at Harvard Medical School. His academic research focuses on health insurance payment systems and markets. He is also a nonresident fellow at the USC-Schaeffer Center and a nonresident fellow in health policy at the American Enterprise Institute.
-
Paying for Advance Care Planning in Medicare: Impacts on Care and Spending Near End of Life
Paying for advance care planning services can be promising in improving patients’ quality of life at end of life (EOL) while lowering EOL spending, especially for patients most vulnerable to receiving aggressive EOL care.
Categorized in -
Want Lower Obesity Drug Costs? Medicare Holds the Key
Medicare coverage will catalyze market competition
Categorized in -
Comments on CBO Blog Post: “A Call for New Research in the Area of Obesity”
While there are significant data and methodological challenges to be overcome, there are better alternatives to simplistically extrapolating from the real-world data on AOM use that is currently available.
Categorized in -
Government And Commercial Insurer Payment Rates to Hospitals: A Commentary on Priselac
Paul Ginsburg discusses how for decades, stakeholders have argued about whether competition or regulation should be the approach to constrain health care spending. By having chosen neither, he argues, our nation now finds itself with a much larger challenge. The magnitude of our health care affordability problem cries out for pursuing both competition and regulation.
Categorized in -
Healthcare Utilization Before and After a Dementia Diagnosis in Medicare Advantage Versus Traditional Medicare
The increase in care use leading up to a dementia diagnosis is higher among beneficiaries in traditional Medicare than in Advantage plans and remains higher after diagnosis.